RUNX1 and mixed phenotype acute leukemia: Furthermore, single-cell omics has been used to reveal epigenetic alternations in mixed phenotype acute leukemia (MPAL), in which RUNX1 may act as a potential oncogene, resulting in poor survival of MPAL patients [52].